Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 5/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11030932 | 0.86 | — | — | |
| SCHEMBL7772397 | 0.84 | ALDH1A1 (0.54) | ALDH1A1ATMTSHRHPGDRAB9A | |
| SCHEMBL8908162 | 0.82 | CHRNB2 (0.58) | ALDH1A1ATMTSHRHPGDRAB9A | |
| SCHEMBL855004 | 0.81 | ALDH1A1 (0.50) | ALDH1A1ATMTSHRHPGDRAB9A | |
| SCHEMBL30532490 | 0.79 | ALDH1A1 (0.48) | ALDH1A1ATMTSHRHPGDRAB9A | |
| SCHEMBL2400945 | 0.79 | NAAA (0.53) | ALDH1A1ATMTSHRRAB9AMAPT | |
| Methylhydrazine SCHEMBL11031292 | 0.79 | ALDH1A1 (0.37) | ALDH1A1TSHRHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL10918173 | 0.78 | ALDH1A1 (0.52) | ALDH1A1ATMTSHRHPGDRAB9A | |
| SCHEMBL28046263 | 0.78 | ALDH1A1 (0.52) | ALDH1A1ATMTSHRHPGDRAB9A | |
| SCHEMBL16119487 | 0.78 | ALDH1A1 (0.52) | ALDH1A1ATMTSHRHPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2470688-A1 | FOCUSED ION BEAM PROCESS FOR SELECTIVE AND CLEAN ETCHING OF COPPER | Tiza Lab, L.L.C. (US) | 2012-07-04 | — | — | EP | claimed |
| WO-2011025770-A1 | FOCUSED ION BEAM PROCESS FOR SELECTIVE AND CLEAN ETCHING OF COPPER | TIZA LAB, L.L.C. (US) | 2011-03-03 | — | — | WO | claimed |
| EP-4519266-A1 | AZEPINOINDOLES AND METHODS OF PREPARATION THEREOF | Bright Minds Biosciences Inc. (CA) | 2025-03-12 | — | — | EP | disclosed |
| WO-2024054845-A1 | MACROCYCIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | SIONNA THERAPEUTICS (US) | 2024-03-14 | — | — | WO | disclosed |
| WO-2023212811-A1 | AZEPINOINDOLES AND METHODS OF PREPARATION THEREOF | BRIGHT MINDS BIOSCIENCES INC. (CA) | 2023-11-09 | — | — | WO | disclosed |
| EP-3856747-A1 | SUBSTITUTED PYRIDOINDOLES FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | F. Hoffmann-La Roche AG (CH) | 2021-08-04 | — | — | EP | disclosed |
| WO-2020064661-A1 | SUBSTITUTED PYRIDOINDOLES FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2020-04-02 | — | — | WO | disclosed |
| EP-3501546-A2 | CYSTEINE DRUG CONJUGATES AND USE OF SAME | Seattle Genetics, Inc. (US) | 2019-06-26 | — | — | EP | disclosed |
| EP-3277690-A1 | SPIROCYCLIC COMPOUNDS | Kalyra Pharmaceuticals, Inc. (US) | 2018-02-07 | — | — | EP | disclosed |
| WO-2016161160-A1 | SPIROCYCLIC COMPOUNDS | KALYRA PHARMACEUTICALS, INC. (US) | 2016-10-06 | — | — | WO | disclosed |
| US-8894828-B2 | FIB process for selective and clean etching of copper | Tiza Lab, LLC (US) | 2014-11-25 | — | — | US | disclosed |
| CN-85108618-A | The preparation method of benzene-fused heterocyclic compound | — | 1986-08-27 | — | — | CN | disclosed |
| US-4440775-A | HISTAMINE H2-ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1984-04-03 | — | — | US | disclosed |
| US-4347250-A | ANTIHISTAMINES; ANTISECRETORY, CARDIOTONIC, AND ANTI-INFLAMMATORY AGENTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1982-08-31 | — | — | US | disclosed |
| US-4333946-A | ANTIINFLAMMATORY AGENTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1982-06-08 | — | — | US | disclosed |
| US-4276301-A | HISTAMINE ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1981-06-30 | — | — | US | disclosed |
| US-4247558-A | HISTAMINE ANTAGONIST | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1981-01-27 | — | — | US | disclosed |
| US-4192879-A | HISTAMINE H2-ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1980-03-11 | — | — | US | disclosed |
| US-4166856-A | Thiazole and isothiazole derivative as blockers of histamine H2 -receptors | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-09-04 | — | — | US | disclosed |
| US-4098898-A | N-SUBSTITUTED-N'-HETEROCYCLIC ALKYLTHIOUREAS, GUANIDINES, AND ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1978-07-04 | — | — | US | disclosed |